Exela Appoints Kevin Lathrop as President of Exela Healthcare Solutions
#Business
- Exela Healthcare Solutions gearing up for growth in the healthcare sector
Kevin will lead Exela’s healthcare line of business and collaborate closely with leaders across the enterprise to drive Exela’s business strategy and value proposition. Kevin will be directly responsible for the growth and performance of HS.
“These investments are part of our overall strategy to create business units for growth within our portfolio and we are already showing progress. We look forward to sharing more with customers, investors and Exelarators as we achieve new milestones,” said
“Healthcare Solutions is a significant driver of Exela’s business on multiple levels. We continue to create solutions that optimize for time and cost for payers, providers, and patients. I am excited to work with Eokesh Natarajan,
Kevin brings a wealth of experience in leading large organizations and operational process enhancements from many well-known companies. Most recently, Kevin served as President and Chief Operating Officer for
Further, within the Exela HS organization,
Chris brings over 35 years of combined Health Information Management experience to
Eokesh has been at
For more
And please follow us on social:
Twitter: https://twitter.com/exelatech
LinkedIn: https://www.linkedin.com/company/exela-technologies
Facebook: https://www.facebook.com/exelatechnologies/
Instagram: https://www.instagram.com/exelatechnologies
The information posted on the Company's website and/or via its social media accounts may be deemed material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website and its social media accounts in addition to the Company's press releases, SEC filings and public conference calls and webcasts.
About Exela Technologies
Forward-Looking Statements
Certain statements included in this press release are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "may", "should", "would", "plan", "intend", "anticipate", "believe", "estimate", "predict", "potential", "seem", "seek", "continue", "future", "will", "expect", "outlook" or other similar words, phrases or expressions. These forward-looking statements include statements regarding our industry, future events, estimated or anticipated future results and benefits, future opportunities for Exela, and other statements that are not historical facts. These statements are based on the current expectations of Exela management and are not predictions of actual performance. These statements are subject to a number of risks and uncertainties, including without limitation those discussed under the heading "Risk Factors" in Exela's Annual Report and other securities filings. In addition, forward-looking statements provide Exela's expectations, plans or forecasts of future events and views as of the date of this communication. Exela anticipates that subsequent events and developments will cause Exela's assessments to change. These forward-looking statements should not be relied upon as representing Exela's assessments as of any date subsequent to the date of this press release.
Investor and Media Contacts:
E: vincent.kondaveeti@exelatech.com
E: IR@exelatech.com
![](https://ml.globenewswire.com/media/Y2VjYjcyNzMtZWMwYy00MjZlLTkzYzQtYzU4OWE3MmYxNGJiLTEwOTc3Mjc=/tiny/Exela-Technologies-Inc-.png)
Source: Exela Technologies, Inc.